Consult & assess
The whole face, treatment area, medical history, previous injectables and priorities are reviewed.
RADIESSE · BURFORD, OXFORDSHIRE
Calcium-hydroxylapatite treatment for selected structural support and biostimulatory goals.
Radiesse is a calcium-hydroxylapatite, or CaHA, injectable suspended in a gel carrier. Depending on how it is prepared and where it is placed, it may be used for selected structural or skin-quality objectives. At Face for Soul, the concern and anatomy come before the product.
01 · THE TREATMENT
Radiesse contains synthetic calcium-hydroxylapatite microspheres suspended in a carboxymethylcellulose-based gel carrier.
In its standard form, the gel provides immediate physical support while the CaHA particles remain in the tissue. Published literature also describes a longer-term tissue response involving collagen and extracellular-matrix remodelling.
When CaHA is diluted or hyperdiluted, the balance shifts away from immediate volumisation towards wider product spread and biostimulatory skin-quality goals. These approaches should not be treated as interchangeable with structural placement, and not every technique is appropriate for every area.
Support, contour, skin quality, laxity, movement, tissue thickness and previous injectables are reviewed together.
The plan distinguishes structural support from a more diffuse biostimulatory skin-quality goal.
Product preparation, dilution, depth and placement are chosen for the anatomy and intended outcome.
The immediate and longer-term response are reassessed before further treatment is considered.
RADIESSE MAY BE DISCUSSED WHEN YOU NOTICE
02 · SUITABILITY
CaHA can behave differently depending on preparation and placement. A jawline support plan is not the same procedure as a diffuse skin-quality treatment, even when both use Radiesse.
01 MAY BE CONSIDERED
02 ANOTHER ROUTE MAY FIT BETTER
VAIVA'S ASSESSMENT
Assessment distinguishes structural support from biostimulatory skin-quality treatment and checks whether CaHA is the right mechanism for the specific area.
Burford · West Oxfordshire · Cotswolds
Volume loss, contour change and tissue descent are separated from normal anatomy and from surface skin concerns.
Thickness, laxity, crepiness, hydration and barrier status help determine whether a diffuse biostimulatory route is relevant.
Depth and anatomy matter because CaHA is not appropriate for every facial region or tissue plane.
Existing filler, previous biostimulators and any prior complications influence planning.
Health, medicines, allergies, infection risk and healing history are reviewed before treatment.
Dermal filler, Sculptra, Profhilo, energy-based treatment, skincare or no treatment may fit better.
Radiesse structural / Radiesse biostimulatory / dermal filler / Sculptra / skin-quality treatment / wait / no treatment
CLINICAL RESTRAINT
03 · APPOINTMENT
Preparation, dilution, delivery method and treatment area depend on whether the objective is structural support or a more diffuse biostimulatory effect.
The whole face, treatment area, medical history, previous injectables and priorities are reviewed.
Vaiva decides whether CaHA, HA filler, Sculptra, another skin-quality treatment or no treatment is the better route.
Radiesse is prepared and placed according to the selected technique, anatomy and treatment objective.
Swelling, redness, tenderness or bruising may occur. Specific aftercare depends on the treatment area and technique.
Immediate support and longer-term tissue change are judged separately before further treatment is planned.
04 · RESULTS & RECOVERY
Structural use can create an immediate change. Swelling can temporarily exaggerate that effect.
Redness, tenderness and bruising usually reduce as the treatment area settles.
Biostimulatory changes in collagen and extracellular matrix develop more gradually.
Further treatment depends on anatomy, response and whether the original objective has been met.
For structural treatment, the goal may be more balanced support or contour. For diluted treatment, the objective may be improvement in laxity or selected skin-quality measures. The treatment plan should make clear which outcome is actually being pursued.
There is no universal course. Structural treatment may be reviewed differently from a biostimulatory skin-quality plan, and published protocols vary by area, dilution and technique.
Bruising, redness, swelling, pain, tenderness, nodules and infection can occur. As with other injectable fillers, unintended intravascular injection can cause serious complications including skin necrosis, visual impairment or stroke. Unlike hyaluronic-acid filler, the calcium-hydroxylapatite component cannot simply be dissolved with hyaluronidase, so appropriate product selection, anatomy and placement are particularly important.
05 · BEFORE & AFTERCARE
Structural CaHA and diluted biostimulatory CaHA are not identical procedures. Follow the instructions given for your treatment area and technique.
Tell the clinic about medicines, supplements, allergies, previous injectables, recent procedures and any changes in health.
Minimise unnecessary pressure or manipulation and follow the area-specific instructions provided after treatment.
Keep skincare simple around treatment and maintain appropriate daily photoprotection once the skin has settled.
SKIN APOTHECARY
Products are shown only when available online and should support the wider plan rather than be treated as an injectable substitute.
Explore medical skincare →
A facial serum option for selected skin-quality plans alongside in-clinic treatment.
View product →
Moisture and barrier support for selected post-procedure skincare routines.
View product →
Daily mineral SPF support for exposed skin.
View product →NOT SURE WHETHER YOU NEED SUPPORT OR SKIN-QUALITY TREATMENT?
Radiesse, Sculptra and hyaluronic-acid filler are not interchangeable treatments.
06 · CHOOSING THE MECHANISM
Radiesse can be used differently according to the objective. It still should not be treated as a substitute term for filler, Sculptra or a skin booster.
07 · CLINICAL EVIDENCE
A 2024 systematic review of facial Radiesse and calcium-hydroxylapatite/carboxymethylcellulose literature supported established filling and contouring uses in selected areas, while noting variation in technique and indication. A separate 2024 systematic review of 13 controlled clinical trials, including eight facial studies, reported favourable aesthetic outcomes but substantial heterogeneity. By contrast, diluted and hyperdiluted CaHA for skin tightening and biostimulation is supported mainly by consensus guidance and observational literature; the facial systematic review noted that no randomised controlled trials of these diluted techniques had been published in the evidence it assessed. A 2023 narrative review summarised biological data relating to collagen, elastin and extracellular-matrix effects. This supports a cautious distinction between conventional structural use and the less mature evidence base for diluted biostimulatory techniques.
08 · LONGER-TERM PLANNING
Some patients may later need additional structural support, a skin-quality treatment or another mechanism entirely. The original diagnosis should be revisited rather than automatically repeating the same product.
09 · FAQs
Radiesse is an injectable implant containing synthetic calcium-hydroxylapatite microspheres suspended in a gel carrier. How it is used depends on the treatment area and clinical objective.
It can provide immediate structural support and is commonly grouped with dermal fillers, but its calcium-hydroxylapatite material and longer-term tissue response differ from hyaluronic-acid gel fillers.
It refers to CaHA being diluted to reduce the emphasis on immediate volumisation and increase spread across a wider treatment area. Published consensus guidance describes this approach for selected laxity and skin-quality goals, but technique and suitability are area-specific.
Hyaluronidase dissolves hyaluronic acid, not calcium hydroxylapatite itself. This is one reason product choice, anatomy, placement and conservative planning matter.
They are different materials with different handling and treatment characteristics. Radiesse contains CaHA and can provide structural support as well as biostimulatory use, while Sculptra uses PLLA and is planned around gradual biostimulatory change.
Hyaluronic-acid filler may be preferable when precise, reversible structural support is the priority. Radiesse may be considered where CaHA's structural or biostimulatory properties fit the anatomy and treatment goal.
Common short-term effects include redness, swelling, pain, tenderness and bruising. Nodules and infection can occur. Rare but serious complications from intravascular injection of facial fillers can include skin necrosis, visual impairment or stroke.
Face for Soul is based in Burford, Oxfordshire, welcoming patients from West Oxfordshire and across the Cotswolds. Treatment follows consultation and suitability assessment.